Market Speculator Part-Time | Swing Trade Report
The post Market Speculator Part-Time | Swing Trade Report appeared first on Bulls on Wall Street.
Similar Posts
Up 22.81%: Is NFI Stock a Buy in June?
Image source: Getty Images Until Tesla came along, a realistic move for the world away from internal combustion engine (ICE) vehicles was little more than a pipe dream. The rise of electric vehicles (EVs) and continuous improvements in the industry are making it more realistic to transition from fossil fuel-guzzling cars to cleaner modes of transportation….
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS was on a selling spree on Friday as the Zurich-based bank and financial services company sold its holding in four stocks through UBS Principal Capital Asia Limited via block deals. The stocks included Concord Biotech, Five Star Business Finance, IIFL Securities and Marksans Pharma and the total share sale aggregated to Rs 480 crore….
Global Equities: Ratcheting Up Downside Protection
Global Equities: Ratcheting Up Downside Protection Source link
Dr. Clemen Chiang’s 2025 Financial Success Insights
As we usher in 2025, it’s the perfect time to reflect on how we can take control of our financial future. Dr. Clemen Chiang, CEO and Founder of Spiking, recently shared his profound insights in the Kiplinger article, “Eight Goals to Jump-Start Your Financial Success in 2025.” He emphasised the importance of prioritising mobility and…
Zydus Life Gets Tentative FDA Nod for Diabetes Tablets; Shares Trade Flat
November 28, 2025November 28, 2025 Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 947.95 on 28th November, despite the firm announced on Thursday (27th November) that it has received tentative approval from the United States Food and Drug Administration (FDA) for empagliflozin…
